A Reintroduction to Attentive Science
We invite you to take a closer look at Attentive - you'll be happy with what you find.
You have choices to make for your project. Determining the right CRO will be key among those decisions. As a niche provider of nonclinical in-vivo services to the industry, Attentive has been expanding its ability to serve our customers with investments in our people, equipment and facilities. Our promise to you is to continually improve on providing our services and to advance our laboratories to serve your needs when it comes to reliable and competent data for your discovery and development programs. We invite you to take a closer look at Attentive – you’ll be happy with what you find.

About Attentive

Attentive Science is a nimble Non-clinical Contract Research Organization (CRO) with the resources to support your mission. Our experienced scientists provide the highest quality results coupled with segment leading expediency and flexible solutions to meet your specific needs. Quality requires constant training; hence training is non-negotiable in the scientific research industry. With highly trained industry veterans at Attentive Science, there is less time spent on “fixing errors”, saving everybody time, more time is spent on your project creating a more high-quality product for the preclinical CRO industry. It is now well known that some of the “big guys” are actually skipping regular quality training and putting projects at risk.  In an industry where quality is paramount, we must stay on top of training.

In your mission to enrich worldwide quality of life via creation of innovative Pharmaceutical, Animal Health, Agrochemical and Food Products, there are challenges. At Attentive, your mission is our focus and we provide In-vivo services in support of your mission. As a boutique provider of nonclinical services to the industry, you will not get more attention from anywhere else. Period. We listen and are able to tackle your challenges together with you. Attentive Science actually delivers on its promise. If we say we can, we will deliver on the NEW “Attentive” level of service. As a relatively small preclinical CRO, Attentive is leading the charge in raising the bar for CRO’s. We invite you to come experience a level of service you’ve never had within this industry. By choosing to partner with Attentive Science, your pipeline will reach its full potential by creating outcomes the world needs for a healthier future.

About Our CEO


Dr. Alfred Botchway has over 25 years’ experience including academic, pharmaceutical and contract research organization tenure performing research studies designed to; investigate pharmacokinetic / pharmacodynamics profiles, minimize potential toxic and/or undesirable effects of agrochemical, biotechnological and pharmaceutical products on physiological functions prior to administration to the intended population.

Dr. Botchway was the founder of Xenometrics a non-clinical contract research organization that provided pharmacokinetic, toxicological and safety pharmacology services to the biopharmaceutical and agrochemical industry. Subsequent to 12 years of successfully operating Xenometrics, Alfred exited Xenometrics a year after its sale to a multinational contract research organization. Alfred is an active member of several international scholastic professional scientific organizations. Alfred served as the President of the International Safety Pharmacology Society and continues to be an active Past President.  Most recently, Alfred served as the interim President and Board Chair of BioKansas, a state trade organization for bioscience companies.

Dr. Botchway holds a BSc and an MSc in Biomedical Science from the University of Kingston, Surrey, UK and the North East College of Technology, Surrey, UK, respectively. By virtue of his masters (hematology major), he developed a keen interest in cardiovascular physiology.  Subsequent to a special interest and research in electrophysiological changes associated with regression of left ventricular hypertrophy, Alfred was awarded a Ph.D. from the Imperial College of Science, Technology and Medicine, London, UK.  Dr Alfred Botchway is also a Diplomate of the international Safety Pharmacology Society.

About Attentive's Services

Pharmacokinetic Services

With Attentive, you have at your disposal a wide range of in-vivo test systems as well as protocols and reporting infrastructure to ensure you receive quality data in a timely manner to select the best test substance and doses for your programs.

· High Throughput PK
· Long Term PK
· Comprehensive Dosing Routes
· Partner Workflow Streams
· Formulation Screening

Toxicology Services

Attentive’s processes ensure transparent communication, collaboration and dialogue that will keep up with your ever-changing needs for lead optimization, candidate selection as well as regulatory-enabling studies.

· Discovery Testing Services
· Maximum Tolerated Dose
· Dose Range Finding
· Acute/Chronic/Subchronic Studies

Safety Pharmacology

In addition to you obtaining scientifically robust data, you have access to a vast network of experts at Attentive.

· Cardiovascular
· Central Nervous System
· Respiratory

Specialty Studies

Companion animal health and safety is important to the One Health Initiative. From management of weight loss of your best companion through to treatment of ailments or severe chronic conditions, you have a range of alternatives available to you with Attentive.

· Target Animal Health/Safety
· Ensuring Safe Food Supply
· Investigational New Drug (IND Studies)

We understand the limitations of our current times that may keep visitors from roaming about our laboratories for now, but even with that limitation, we are technology-enabled to provide a virtual tour – let us know when you are available and we will show you around!

We look forward to hearing from you!

Attentive's Website: Updated with YOU in Mind
No matter where you are or what you're using, Attentive's updated site is device responsive!